Trial intelligence / Profile preview

IV Lidocaine vs ESPB for Post-PCNL Analgesia

NCT06078241Completed

Sponsor
Ain Shams University
Start
Nov 2023
Primary completion
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Time to first rescue analgesia at 24 hours. Started Nov 2023; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06078241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06078241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call